{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:26:36Z","timestamp":1792074396746,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.neulet.2009.09.003","type":"journal-article","created":{"date-parts":[[2009,9,5]],"date-time":"2009-09-05T09:06:58Z","timestamp":1252141618000},"page":"108-112","source":"Crossref","is-referenced-by-count":13,"title":["Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy"],"prefix":"10.1016","volume":"465","author":[{"given":"David","family":"Balayssac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Maublant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Penault-Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Eschalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Coudor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2009.09.003_bib1","first-page":"47","article-title":"Increased brain P-glycoprotein in morphine tolerant rats","volume":"66","author":"Aquilante","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2009.09.003_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0014-4886(03)00003-7","article-title":"An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections","volume":"182","author":"Authier","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2009.09.003_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2006.06.055","article-title":"Involvement of the multidrug resistance transporters in cisplatin-induced neuropathy in rats. Comparison with the chronic constriction injury model and monoarthritic rats","volume":"544","author":"Balayssac","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2009.09.003_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1046\/j.1471-4159.2003.01990.x","article-title":"Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood\u2013brain barrier","volume":"86","author":"Bourasset","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2009.09.003_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","article-title":"Association of ABCB1\/MDR1 and OPRM1 gene polymorphisms with morphine pain relief","volume":"83","author":"Campa","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2009.09.003_bib6","first-page":"672","article-title":"Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents","volume":"40","author":"Cayre","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2009.09.003_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0885-3924(03)00064-2","article-title":"Diagnosis and treatment of neuropathic pain","volume":"25","author":"Chong","year":"2003","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.neulet.2009.09.003_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF02261241","article-title":"Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention","volume":"20","author":"Crane","year":"1993","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.neulet.2009.09.003_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2003.08.027","article-title":"Variable modulation of opioid brain uptake by P-glycoprotein in mice","volume":"67","author":"Dagenais","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2009.09.003_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.051","article-title":"Pharmacological characterization of the chronic constriction injury model of neuropathic pain","volume":"491","author":"De Vry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2009.09.003_bib11","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2009.09.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/1266761","article-title":"Procedures for detecting outlying observations in samples","volume":"11","author":"Grubbs","year":"1969","journal-title":"Technometrics"},{"key":"10.1016\/j.neulet.2009.09.003_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-4-10","article-title":"Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies","volume":"4","author":"Jimenez-Andrade","year":"2008","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neulet.2009.09.003_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0090-9556(24)11822-3","article-title":"Effects of a potent and specific P-glycoprotein inhibitor on the blood\u2013brain barrier distribution and antinociceptive effect of morphine in the rat","volume":"27","author":"Letrent","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neulet.2009.09.003_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuropharm.2007.07.012","article-title":"Increased P-glycoprotein expression and decreased phenobarbital distribution in the brain of pentylenetetrazole-kindled rats","volume":"53","author":"Liu","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2009.09.003_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1471-4159.2002.01177.x","article-title":"Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein","volume":"83","author":"Lotsch","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2009.09.003_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2004.03.010","article-title":"Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model","volume":"110","author":"Lynch 3rd","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2009.09.003_bib18","first-page":"922","article-title":"Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes","volume":"37","author":"Maublant","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2009.09.003_bib19","first-page":"48","article-title":"Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells","volume":"29","author":"Maublant","year":"1988","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2009.09.003_bib20","first-page":"977","article-title":"Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex","volume":"53","author":"Piwnica-Worms","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.neulet.2009.09.003_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2009.09.003_bib22","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neulet.2009.09.003_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/00016480152602212","article-title":"Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A","volume":"121","author":"Saito","year":"2001","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.neulet.2009.09.003_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neulet.2009.09.003_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control."},{"key":"10.1016\/j.neulet.2009.09.003_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","article-title":"MDR1 gene expression in brain of patients with medically intractable epilepsy","volume":"36","author":"Tishler","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.neulet.2009.09.003_bib27","first-page":"1365","article-title":"The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel","volume":"6","author":"van Zuylen","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neulet.2009.09.003_bib28","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0169-409X(03)00100-5","article-title":"Pain and the blood\u2013brain barrier: obstacles to drug delivery","volume":"55","author":"Wolka","year":"2003","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394009011963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394009011963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:52:57Z","timestamp":1739321577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394009011963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0304394009011963"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2009.09.003","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}